506879 Stock Overview
Gujarat Themis Biosyn Limited engages in the manufacturing of pharmaceuticals and medicinal chemicals in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 506879 from our risk checks.
Gujarat Themis Biosyn Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹398.50 |
| 52 Week High | ₹435.00 |
| 52 Week Low | ₹145.80 |
| Beta | -0.15 |
| 1 Month Change | 0.025% |
| 3 Month Change | 14.04% |
| 1 Year Change | 151.31% |
| 3 Year Change | 648.78% |
| 5 Year Change | 5,041.94% |
| Change since IPO | 66,316.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506879 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.6% | -3.4% | -3.7% |
| 1Y | 151.3% | 53.6% | 38.4% |
Return vs Industry: 506879 exceeded the Indian Pharmaceuticals industry which returned 53.6% over the past year.
Return vs Market: 506879 exceeded the Indian Market which returned 38.4% over the past year.
Price Volatility
| 506879 volatility | |
|---|---|
| 506879 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 506879 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506879's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 109 | Guha Guhathakurata | www.gtbl.in |
Gujarat Themis Biosyn Limited engages in the manufacturing of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin.
Gujarat Themis Biosyn Limited Fundamentals Summary
| 506879 fundamental statistics | |
|---|---|
| Market cap | ₹28.77b |
| Earnings (TTM) | ₹549.70m |
| Revenue (TTM) | ₹1.56b |
52.7x
P/E Ratio18.5x
P/S RatioIs 506879 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506879 income statement (TTM) | |
|---|---|
| Revenue | ₹1.56b |
| Cost of Revenue | ₹313.03m |
| Gross Profit | ₹1.25b |
| Other Expenses | ₹700.00m |
| Earnings | ₹549.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 7.57 |
| Gross Margin | 79.97% |
| Net Profit Margin | 35.18% |
| Debt/Equity Ratio | 1.3% |
How did 506879 perform over the long term?
See historical performance and comparison